T

Tavistock Group

103 employees

Tavistock Life Sciences is a venture capital investment firm specialized in earl-stage investments.

Investor insights

Countries invested in

united states2

Sectors invested in

Biotechnology18
Health Care15
Therapeutics12
Biopharma8
Life Science6
Medical5
Pharmaceutical3
Genetics2
Oncology2
Biomarkers1
Cancer / Oncology1
Developer Platform1
Drug Discovery and Development1
Product Research1
Bioinformatics1
Software1
Internet of Things1
Fleet Management1
Telecommunications1
Pet1

Funding rounds participated in

$31M sweet spot round size

Most of their 21 investments are in rounds between $13M and $60M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Asset Management

Date founded

1975

Investments made

K

KinoTek Software raised $600K on February 17, 2021

Investors: Maine Technology Institute, leAD Sports and Tavistock Group

N

Nuvation Bio raised $502M on February 11, 2021

Investors: Omega Funds, OrbiMed Advisors, The Baupost Group, Perceptive Advisors, Wellington Management, Surveyor Capital, Redmile Group, Irving Investors, Monashee Investment Management LLC and Tavistock Group

M

Mereo BioPharma raised $70M on June 4, 2020

Investors: Commodore Capital, LP, OrbiMed Advisors, Samsara BioCapital, Aspire Capital Partners, LLC, Vivo Capital, Pontifax Venture Capital, Surveyor Capital and Tavistock Group

R

Relay Therapeutics raised $400M on December 20, 2018

Investors: D. E. Shaw Research, Foresite Capital, Perceptive Advisors, SoftBank Investment Advisers, Casdin Capital, LLC, GV and Tavistock Group

A

Avidity Biosciences raised $16M on October 17, 2018

Investors: Alethea Capital Management LLC, Brace Pharma Capital, F-Prime Capital Partners, Moore Venture Partners and Tavistock Group

A

Atreca, Inc. raised $125M on September 12, 2018

Investors: Aisling Capital, Samsara BioCapital, Tekla Capital Management, Redmile Group, Wellington Management and Tavistock Group

I

Inseego Corp raised $20M on August 7, 2018

Investors: Tavistock Group

P

Poseida Therapeutics, Inc. raised $31M on April 3, 2018

Investors: Malin Corporation plc, Vivo Capital, Longitude Capital and Tavistock Group

G

G1 Therapeutics, Inc. raised $47M on May 11, 2016

Investors: Lumira Ventures, Mountain Group Partners, RA Capital Management, L.P., Eshelman Ventures, LLC, Cowen Inc. and Tavistock Group

K

Kura Oncology, Inc. raised $60M on March 12, 2015

Investors: Nextech Invest, ARCH Venture Partners, -, Osage University Partners (OUP) and Tavistock Group

FAQ